NCT03904290View on ClinicalTrials.gov

Does Patent Foramen Ovale Closure Improve Exercise Capacity & Prevent Blood Flow Through Intrapulmonary Shunt

NAEnrolling by invitationINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 5, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Patent Foramen Ovale
Interventions
OTHER

PFO Closure

Subject will undergo percutaneous closure of PFO/ASD utilizing FDA-approved PFO/ASD closure device(s).

Trial Locations (1)

97403

Cardiorespiratory and Pulmonary Physiology Lab, Eugene

All Listed Sponsors
lead

University of Oregon

OTHER